Drug Shortage Report for THALOMID
Report ID | 228619 |
Drug Identification Number | 02355191 |
Brand name | THALOMID |
Common or Proper name | THALIDOMIDE |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | MARKETED |
Active Ingredient(s) | THALIDOMIDE |
Strength(s) | 50MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 2X14 |
ATC code | L04AX |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-05-24 |
Actual start date | |
Estimated end date | 2024-06-24 |
Actual end date | 2024-06-12 |
Shortage status | Resolved |
Updated date | 2024-06-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-06-13 | English | Compare |
v7 | 2024-06-12 | French | Compare |
v6 | 2024-06-12 | English | Compare |
v5 | 2024-05-25 | French | Compare |
v4 | 2024-05-24 | French | Compare |
v3 | 2024-05-24 | English | Compare |
v2 | 2024-05-24 | French | Compare |
v1 | 2024-05-24 | English | Compare |
Showing 1 to 8 of 8